Affinity Asset Advisors’s Zymeworks ZYME Stock Holding History
Bought
Maintained
Sold
Other funds holding ZYME
EC
RG
BI
RCMNY
PA
Affinity Asset Advisors's ZYME Position: Q3 2024 in Review
Affinity Asset Advisors sold out of Zymeworks (ZYME) in Q3 2024, closing a stake of 191,127 shares — an estimated $1.63M sold.
Affinity Asset Advisors first reported a position in ZYME in Q4 2020 and held it in 5 quarters. The position peaked at $3.07M in Q4 2020. 163 funds tracked by Wall St. Rank hold ZYME as of Q3 2024.
- Affinity Asset Advisors reported no remaining Zymeworks position as of Q3 2024 after selling out during the quarter.
- Affinity Asset Advisors sold 191,127 Zymeworks shares in Q3 2024, an estimated $1.63M.
- Affinity Asset Advisors first reported a position in Zymeworks in Q4 2020 and held it in 5 quarters.
- Affinity Asset Advisors's Zymeworks position peaked at $3.07M in Q4 2020.
- 163 funds tracked by Wall St. Rank held Zymeworks as of Q3 2024.
Based on Affinity Asset Advisors's 13F filing for Q3 2024, filed 13 Nov 2024.